We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
The main lines of research on the disease are focused on improving tools to prevent, diagnose and cure the disease.
There are several vaccine candidates in the clinical development phase. Their objective is to improve the efficacy of the BCG vaccine against infection and disease. The BCG vaccine does not offer protection against the most frequent tuberculosis, which is pulmonary tuberculosis in adults.
Also, new antibiotics and short-term preventive schemes are being developed. In the field of treatment, there are several clinical trials aimed at reducing the duration of antibiotic treatment, with a shorter scheme of 4 months; however, this is not yet available in Spain or other European countries.
In a proportion of tuberculosis cases, bacteriological confirmation is not achieved, especially in the paediatric population. For this reason, new molecular tools and biomarkers are being investigated to contribute to better, earlier diagnosis of the disease.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Alberto García-BasteiroMedicina preventiva y epidemiologíaEpidemiólogo
Jose Antonio Martinez MartinezEnfermedades InfecciosasEspecialista en enfermedades infecciosas
Published: 1 February 2023
Updated: 1 February 2023
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.